sulfadiazine has been researched along with Congenital Infection, Toxoplasma gondii in 93 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 9.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
| "This was a randomized, open-label trial in 36 French centers, comparing pyrimethamine (50 mg qd) + sulfadiazine (1 g tid) with folinic acid vs spiramycin (1 g tid) following toxoplasmosis seroconversion." | 5.27 | Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. ( Berrebi, A; Biquard, F; Bory, JP; Cordier, AG; d'Ercole, C; Houfflin-Debarge, V; Jouannic, JM; Kieffer, F; Laurichesse-Delmas, H; Le Bouar, G; Mandelbrot, L; Mesnard, L; Perrotin, F; Sitta, R; Thiébaut, R; Ville, Y; Villena, I; Winer, N, 2018) |
| "However, failures in the treatment of toxoplasmosis have been reported, especially in South America, suggesting the acquisition of resistance against SDZ and PYR." | 2.72 | Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations. ( de Almeida Vitor, RW; de Lima Bessa, G; Dos Santos Martins-Duarte, E, 2021) |
| "Pre- and neonatal screening for congenital toxoplasmosis rests upon the assumption that treatment is beneficial on either acute symptoms or in preventing later reactivation." | 2.42 | Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? ( Petersen, E; Schmidt, DR, 2003) |
| "Congenital toxoplasmosis was higher in mothers infected during the third pregnancy trimester, and maternal treatment during pregnancy was not associated with a lower rate of congenital toxoplasmosis." | 1.62 | Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak. ( Belfort, R; Belucik, DN; Commodaro, AG; Conceição, AR; Costa, DF; de Oliveira Dias, JR; Gustavo Brenner, L; Henrique Monteiro, M; Missio, L; Ribeiro, KS; Valadão, MCDS, 2021) |
| "The sulfadiazine suspension in simple syrup was chosen as the most suitable formulation because it demonstrated stability for 14 days at room temperature, providing an alternative liquid dosage form of sulfadiazine for congenital toxoplasmosis treatment." | 1.56 | Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis. ( Barreto Gomes, AP; Mafra Veríssimo, L; Pontes do Nascimento, L; Soares Rodrigues Costa, B; Vítor de Paiva Amorim, M, 2020) |
| " In most cases, it was not severe and reversed after increase in folinic acid dosage (25." | 1.46 | High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil. ( Carellos, EVM; de Andrade, GMQ; de Andrade, JQ; Figueiredo, RM; Januário, JN; Romanelli, RMC; Tibúrcio, JD; Vasconcelos-Santos, DV, 2017) |
| "Question Congenital toxoplasmosis is a dangerous fetal infection." | 1.40 | Toxoplasmosis and pregnancy. ( Chaudhry, SA; Gad, N; Koren, G, 2014) |
| "The birth prevalence of congenital toxoplasmosis is high in the Brazilian state of Sergipe, with most of the infants showing ocular lesions." | 1.38 | Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil. ( Araújo, RM; Carvalheiro, CG; Cipolotti, R; de Melo Inagaki, AD; Gurgel, RQ; Lima, DR; Mussi-Pinhata, MM; Pinheiro, KS; Rocha, DA; Winandy, JL, 2012) |
| "We report a case of congenital toxoplasmosis following infection occurring late in pregnancy." | 1.37 | [Congenital toxoplasmosis following infection occurring late in pregnancy]. ( Aoun, K; Ben Abdallah, R; Bouratbine, A; Maatoug, R; Siala, E; Souissi, O, 2011) |
| "Pyrimethamine was used in a single daily dose at an amount of 0." | 1.37 | Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations. ( Filipek, M; Lipka, B; Milewska-Bobula, B, 2011) |
| "We report a case of fatal congenital toxoplasmosis case in Tunis (North of Tunisia) associated with I/III recombinant genotype." | 1.37 | Case of fatal congenital toxoplasmosis associated with I/III recombinant genotype. ( Aoun, K; Ben-Abdallah, R; Boughattas, S; Bouratbine, A; Maatoug, R; Siala, E; Souissi, O, 2011) |
| "Currently, there is no ideal drug for congenital toxoplasmosis; future research should focus on the screening of new active drugs and on their pre-clinical and early clinical development, with a focus on pharmacokinetic/dynamic studies and teratogenicity." | 1.35 | Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. ( Chêne, G; Thiébaut, R, 2009) |
| "Fourteen cataracts were present at birth and 13 developed postnatally." | 1.34 | Cataracts in congenital toxoplasmosis. ( Alam, A; Arun, V; Boyer, K; Cezar, S; Del Monte, MA; Greenwald, MJ; Jalbrzikowski, J; Karrison, T; Kasza, K; Latkany, P; McLeod, R; Mets, MB; Mieler, W; Noble, AG; Rabiah, P; Roizen, N; Sautter, M; Swisher, CN; Troia, RN, 2007) |
| "Pyrimethamine was found to give a linear response using MS detection in the range 0." | 1.33 | Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis. ( Christiansen, I; Hansen, SH; Johannessen, JK; Petersen, E; Schmidt, DR, 2005) |
| "Without treatment, congenital toxoplasmosis has recurrent, recrudescent, adverse outcomes." | 1.33 | Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. ( Boyer, K; Heydemann, P; Holfels, E; Jalbrzikowski, J; Karrison, T; Kasza, K; Latkany, P; McLeod, R; Meier, P; Mets, M; Noble, AG; Remington, J; Roizen, N; Swisher, C; Withers, S, 2006) |
| "To present a case of congenital toxoplasmosis in a newborn whose mother had a 20-year history of a chorioretinal macular scar and positive serology for toxoplasmosis." | 1.32 | Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier. ( Belfort, R; Ferreira, R; Muccioli, C; Nussenblatt, R; Silveira, C, 2003) |
| "Congenital toxoplasmosis is a potentially serious infection which usually affects infants born to non immune women." | 1.32 | [Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman]. ( Baudon, JJ; Ducrocq, S; Gold, F; Lebas, F; Mégier, P; Mucignat, V; Paris, L, 2004) |
| "The treatment of reference of congenital toxoplasmosis combines two folate synthesis inhibitors, pyrimethamine and an antibacterial sulfamide (sulfadiazine or sulfadoxine)." | 1.32 | [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis]. ( Coutty, N; Decocq, J; Delahousse, G; Detourmignies, L; Le Goueff, F; Mubiayi, N, 2004) |
| "Toxoplasmosis was detected in those persons having lymphadenitis, therapeutical patients, women with aggravated obstetrical history having had spontaneous abortions and having given birth to sick children, patients with sluggish meningoencephalitis presenting with epileptoid and hypothalamic syndrome, polyneuritis, and patients with myopia, chorioretinitis and uveitis." | 1.31 | [Toxoplasmosis in sick persons]. ( Netrebko, ID, 2002) |
| "Causes for this visual impairment in eyes with quiescent lesions included macular scars, dragging of the macula secondary to a peripheral lesion, retinal detachment, optic atrophy, cataract, amblyopia, and phthisis." | 1.30 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1997) |
| "Following prenatal treatment, the hydrops fetalis resolved and at four months of age she has normal growth and development." | 1.30 | Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome. ( Blaser, S; Chitayat, D; Ford-Jones, LE; Friedman, S; Ryan, G; Toi, A, 1999) |
| "We report two cases of congenital toxoplasmosis following maternal primary infection occurring late during pregnancy." | 1.30 | [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy]. ( Botterel, F; Bourée, P; Ithier, G; Romand, S; Wirden, M, 1999) |
| "To describe a case of severe congenital toxoplasmosis because of inadequate surveillance of a seronegative pregnant woman and to evaluate the usefulness of different microbiological diagnostic methods after birth." | 1.30 | [Analysis of a case of severe congenital toxoplasmosis]. ( Coll, O; Costa, J; Falgueras, T; Gómez-López, L; Pujol-Riqué, M; Rodríguez-Miguélez, JM; Tudó, G; Valls, ME, 1999) |
| "Six of the 36 children had perinatal seizures." | 1.29 | Neurologic and developmental outcome in treated congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Meier, P; Mets, MB; Patel, D; Roizen, N; Stein, L; Stein, MA; Swisher, CN, 1995) |
| "Most infants with congenital Toxoplasma gondii infection have no symptoms at birth, but many will have retinal disease or neurologic abnormalities later in life." | 1.29 | Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. ( Abroms, I; Eaton, RB; Guerina, NG; Hoff, R; Hsu, HW; Lynfield, R; Maguire, JH; Meissner, HC; Pasternack, MS; Stechenberg, B, 1994) |
| "Causes for this visual impairment in eyes with quiescent lesions included macular scars, dragging of the macula secondary to a peripheral lesion, retinal detachment, optic atrophy, cataract, amblyopia, and phthisis." | 1.29 | Eye manifestations of congenital toxoplasmosis. ( Boyer, KM; Holfels, E; Hopkins, J; Luciano, R; Mack, D; McLeod, R; Meier, P; Mets, MB; Patel, D; Remington, JS; Roizen, N; Stein, L; Stein, M; Swisher, CN; Withers, S, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (25.81) | 18.7374 |
| 1990's | 23 (24.73) | 18.2507 |
| 2000's | 23 (24.73) | 29.6817 |
| 2010's | 19 (20.43) | 24.3611 |
| 2020's | 4 (4.30) | 2.80 |
| Authors | Studies |
|---|---|
| Soares Rodrigues Costa, B | 1 |
| Pontes do Nascimento, L | 1 |
| Vítor de Paiva Amorim, M | 1 |
| Barreto Gomes, AP | 1 |
| Mafra Veríssimo, L | 1 |
| Yamamoto, K | 1 |
| Kutsuna, S | 1 |
| Kato, Y | 1 |
| Goishi, K | 1 |
| Shichino, H | 1 |
| Ohmagari, N | 1 |
| Conceição, AR | 1 |
| Belucik, DN | 1 |
| Missio, L | 1 |
| Gustavo Brenner, L | 1 |
| Henrique Monteiro, M | 1 |
| Ribeiro, KS | 1 |
| Costa, DF | 1 |
| Valadão, MCDS | 1 |
| Commodaro, AG | 1 |
| de Oliveira Dias, JR | 1 |
| Belfort, R | 2 |
| de Lima Bessa, G | 1 |
| de Almeida Vitor, RW | 1 |
| Dos Santos Martins-Duarte, E | 1 |
| Rioualen, S | 1 |
| Dufau, J | 1 |
| Flatres, C | 1 |
| Lavenant, P | 1 |
| Misery, L | 1 |
| Roué, JM | 1 |
| Loveridge-Easther, C | 1 |
| Yardley, AM | 1 |
| Breidenstein, B | 1 |
| Boudaouara, Y | 1 |
| Aoun, K | 3 |
| Maatoug, R | 3 |
| Souissi, O | 3 |
| Bouratbine, A | 3 |
| Abdallah, RB | 1 |
| Mandelbrot, L | 1 |
| Kieffer, F | 2 |
| Sitta, R | 1 |
| Laurichesse-Delmas, H | 1 |
| Winer, N | 1 |
| Mesnard, L | 1 |
| Berrebi, A | 1 |
| Le Bouar, G | 1 |
| Bory, JP | 1 |
| Cordier, AG | 1 |
| Ville, Y | 1 |
| Perrotin, F | 2 |
| Jouannic, JM | 1 |
| Biquard, F | 1 |
| d'Ercole, C | 1 |
| Houfflin-Debarge, V | 1 |
| Villena, I | 1 |
| Thiébaut, R | 2 |
| Silva, LA | 2 |
| Fernandes, MD | 1 |
| Machado, AS | 1 |
| Reis-Cunha, JL | 2 |
| Bartholomeu, DC | 2 |
| Almeida Vitor, RW | 1 |
| Chaudhry, SA | 1 |
| Gad, N | 1 |
| Koren, G | 1 |
| Vítor, RW | 1 |
| Carellos, EVM | 1 |
| de Andrade, JQ | 1 |
| Romanelli, RMC | 1 |
| Tibúrcio, JD | 1 |
| Januário, JN | 1 |
| Vasconcelos-Santos, DV | 1 |
| Figueiredo, RM | 1 |
| de Andrade, GMQ | 1 |
| Guha, R | 1 |
| Miley, L | 1 |
| Aspiri, M | 1 |
| Dhamija, R | 1 |
| Chêne, G | 1 |
| Costa, IN | 1 |
| Angeloni, MB | 1 |
| Santana, LA | 1 |
| Barbosa, BF | 1 |
| Silva, MC | 1 |
| Rodrigues, AA | 1 |
| Rostkowsa, C | 1 |
| Magalhães, PM | 1 |
| Pena, JD | 1 |
| Silva, DA | 1 |
| Mineo, JR | 1 |
| Ferro, EA | 1 |
| Al-Hamod, D | 1 |
| Vauloup, C | 1 |
| Goulet, M | 1 |
| Zupan-Simunek, V | 1 |
| Castel, C | 1 |
| Boileau, P | 1 |
| Röser, D | 1 |
| Nielsen, HV | 1 |
| Petersen, E | 4 |
| Saugmann-Jensen, P | 1 |
| Nørgaard-Pedersen, B | 1 |
| Nørgaard-Pedersen, PB | 1 |
| Mavrikakis, E | 1 |
| Levin, AV | 1 |
| Lam, WC | 1 |
| Ajzenberg, D | 1 |
| Ben Abdallah, R | 1 |
| Siala, E | 2 |
| Lipka, B | 1 |
| Milewska-Bobula, B | 1 |
| Filipek, M | 1 |
| Boughattas, S | 1 |
| Ben-Abdallah, R | 1 |
| Pohl-Schickinger, A | 1 |
| Feiterna-Sperling, C | 1 |
| Weizsäcker, K | 1 |
| Bührer, C | 1 |
| Chuang, YC | 1 |
| Chen, JY | 1 |
| Ji, DD | 1 |
| Su, PH | 1 |
| de Melo Inagaki, AD | 1 |
| Carvalheiro, CG | 1 |
| Cipolotti, R | 1 |
| Gurgel, RQ | 1 |
| Rocha, DA | 1 |
| Pinheiro, KS | 1 |
| Araújo, RM | 1 |
| Lima, DR | 1 |
| Winandy, JL | 1 |
| Mussi-Pinhata, MM | 1 |
| Hill, D | 1 |
| Dubey, JP | 1 |
| Netrebko, ID | 1 |
| Maeda, T | 1 |
| Silveira, C | 1 |
| Ferreira, R | 1 |
| Muccioli, C | 1 |
| Nussenblatt, R | 1 |
| Brady-McCreery, KM | 1 |
| Hussein, MA | 1 |
| Paysse, EA | 1 |
| PULLON, DH | 1 |
| Christoph, J | 1 |
| Kattner, E | 1 |
| Seitz, HM | 1 |
| Reiter-Owona, I | 1 |
| Lebas, F | 1 |
| Ducrocq, S | 1 |
| Mucignat, V | 1 |
| Paris, L | 1 |
| Mégier, P | 1 |
| Baudon, JJ | 1 |
| Gold, F | 1 |
| Schmidt, DR | 3 |
| Mubiayi, N | 1 |
| Coutty, N | 1 |
| Detourmignies, L | 1 |
| Le Goueff, F | 1 |
| Decocq, J | 1 |
| Delahousse, G | 1 |
| Johannessen, JK | 1 |
| Christiansen, I | 1 |
| Hansen, SH | 2 |
| Hogh, B | 1 |
| Andersen, O | 1 |
| Dalhoff, K | 1 |
| Di Carlo, P | 2 |
| Mazzola, A | 2 |
| Romano, A | 2 |
| Schimmenti, MG | 2 |
| Colicchia, P | 1 |
| Bellipanni, P | 1 |
| Titone, L | 2 |
| McLeod, R | 7 |
| Boyer, K | 5 |
| Karrison, T | 3 |
| Kasza, K | 3 |
| Swisher, C | 5 |
| Roizen, N | 9 |
| Jalbrzikowski, J | 3 |
| Remington, J | 3 |
| Heydemann, P | 1 |
| Noble, AG | 3 |
| Mets, M | 5 |
| Holfels, E | 5 |
| Withers, S | 4 |
| Latkany, P | 3 |
| Meier, P | 7 |
| Altcheh, J | 1 |
| Diaz, NS | 1 |
| Pepe, CM | 1 |
| Martin, V | 1 |
| Nigro, M | 1 |
| Freilij, H | 1 |
| Angel, SO | 1 |
| Casuccio, A | 1 |
| Phan, L | 1 |
| Kuo, A | 1 |
| Mieler, W | 2 |
| Meyers, S | 2 |
| Rabiah, P | 3 |
| Cezar, S | 2 |
| Arun, V | 1 |
| Troia, RN | 1 |
| Sautter, M | 1 |
| Greenwald, MJ | 1 |
| Mets, MB | 5 |
| Alam, A | 1 |
| Swisher, CN | 5 |
| Del Monte, MA | 1 |
| EICHENWALD, H | 1 |
| Whitley, RJ | 1 |
| Alford, CA | 1 |
| Couvreur, J | 5 |
| Desmonts, C | 1 |
| van der Veen, J | 1 |
| McCabe, RE | 1 |
| Remington, JS | 5 |
| Bonardi, R | 1 |
| Morales Castillo, ME | 1 |
| Cedillo Rivera, R | 1 |
| Nottin, N | 1 |
| Desmonts, G | 2 |
| Robinson, RO | 1 |
| Baumann, RJ | 1 |
| Stein, MA | 2 |
| Hopkins, J | 5 |
| Boyer, KM | 5 |
| Stein, L | 5 |
| Patel, D | 6 |
| Guerina, NG | 1 |
| Hsu, HW | 1 |
| Meissner, HC | 1 |
| Maguire, JH | 1 |
| Lynfield, R | 1 |
| Stechenberg, B | 1 |
| Abroms, I | 1 |
| Pasternack, MS | 1 |
| Hoff, R | 1 |
| Eaton, RB | 1 |
| McAuley, J | 1 |
| Wolters, C | 1 |
| Stein, M | 3 |
| Schey, W | 1 |
| Wong, SY | 1 |
| Mirlesse, V | 1 |
| Jacquemard, F | 1 |
| Daffos, F | 1 |
| Briese, V | 1 |
| Rogmann, K | 1 |
| Müller, H | 1 |
| Plesse, R | 1 |
| Patel, DV | 1 |
| Holfels, EM | 1 |
| Vogel, NP | 1 |
| Roizen, NJ | 1 |
| Stein, LK | 1 |
| Withers, SE | 1 |
| Mack, DG | 2 |
| Luciano, RA | 1 |
| McLeod, RL | 1 |
| Mack, D | 3 |
| Luciano, R | 2 |
| Cotty, F | 1 |
| Carpentier, MA | 1 |
| Descamps, P | 1 |
| Richard-Lenoble, D | 1 |
| Gratzl, R | 1 |
| Hayde, M | 1 |
| Kohlhauser, C | 1 |
| Hermon, M | 1 |
| Burda, G | 1 |
| Strobl, W | 1 |
| Pollak, A | 1 |
| Friedman, S | 1 |
| Ford-Jones, LE | 1 |
| Toi, A | 1 |
| Ryan, G | 1 |
| Blaser, S | 1 |
| Chitayat, D | 1 |
| Pedreira, DA | 1 |
| Diniz, EM | 1 |
| Schultz, R | 1 |
| Faro, LB | 1 |
| Zugaib, M | 1 |
| Koppe, JG | 2 |
| Meenken, C | 1 |
| Wirden, M | 1 |
| Botterel, F | 1 |
| Romand, S | 3 |
| Ithier, G | 1 |
| Bourée, P | 1 |
| Djurkovic-Djakovic, O | 1 |
| Nobrè, R | 2 |
| Thulliez, P | 2 |
| Pujol-Riqué, M | 1 |
| Gómez-López, L | 1 |
| Tudó, G | 1 |
| Falgueras, T | 1 |
| Costa, J | 1 |
| Rodríguez-Miguélez, JM | 1 |
| Coll, O | 1 |
| Valls, ME | 1 |
| Pfiffner, L | 1 |
| Aitchison, V | 1 |
| Brézin, A | 1 |
| Yi-Gallimard, E | 1 |
| Voyer, M | 1 |
| Magny, JF | 1 |
| Pelloux, H | 1 |
| Fricker-Hidalgo, H | 1 |
| Pons, JC | 1 |
| Bost-Bru, C | 1 |
| Brenier-Pinchart, MP | 1 |
| Jouk, PS | 1 |
| Ambroise-Thomas, P | 1 |
| Lambotte, R | 1 |
| Singh, S | 1 |
| Holliman, RE | 1 |
| Johnson, JD | 1 |
| Constantine, G | 1 |
| Bissenden, JG | 1 |
| Nicolaides, K | 1 |
| Savva, D | 1 |
| Boulot, P | 1 |
| Pratlong, F | 1 |
| Sarda, P | 1 |
| Deschamps, F | 1 |
| Hedon, B | 1 |
| Laffargue, F | 1 |
| Viala, JL | 1 |
| Beckmann, E | 1 |
| Vitullo, D | 1 |
| Johnson, D | 1 |
| Wilson, CB | 1 |
| Mitchell, CD | 1 |
| Erlich, SS | 1 |
| Mastrucci, MT | 1 |
| Hutto, SC | 1 |
| Parks, WP | 1 |
| Scott, GB | 1 |
| Kocher, R | 1 |
| Haensch, G | 1 |
| Fuchs, F | 1 |
| Kimball, AC | 1 |
| Kean, BH | 1 |
| Brys, R | 1 |
| Haemers, J | 1 |
| Barbier, F | 1 |
| Shahin, B | 1 |
| Papadopoulou, ZL | 1 |
| Jenis, EH | 1 |
| Markus, MB | 1 |
| Hogan, MJ | 2 |
| Siim, JC | 1 |
| Krogstad, DJ | 1 |
| Juranek, DD | 1 |
| Walls, KW | 1 |
| Alexander, M | 1 |
| Sedan, J | 1 |
14 reviews available for sulfadiazine and Congenital Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.
Topics: Female; Humans; Pregnancy; South America; Sulfadiazine; Toxoplasma; Toxoplasmosis; Toxoplasmosis, Co | 2021 |
Toxoplasma gondii: transmission, diagnosis and prevention.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Protozoan; Cats; Cattle; Deer; Encephalitis | 2002 |
[Toxoplasmosis].
Topics: Animals; Diagnosis, Differential; Female; Humans; Infant, Newborn; Molecular Diagnostic Techniques; | 2003 |
[Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Topics: Coccidiostats; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Diagn | 2004 |
Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
Topics: Humans; Infant, Newborn; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Congenital | 2003 |
Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections.
Topics: Antiviral Agents; Cytomegalovirus Infections; Herpes Simplex; Humans; Infant, Newborn; Infant, Newbo | 1981 |
Toxoplasmosis in pregnancy.
Topics: Animals; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethami | 1994 |
[Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
Topics: Adult; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Hemagglutination Tests; Hu | 1993 |
Fetal cataract in congenital toxoplasmosis.
Topics: Adolescent; Cataract; Female; Fetal Diseases; Follow-Up Studies; Humans; Hydrocephalus; Infant, Newb | 1999 |
The child with congenital toxoplasmosis.
Topics: Child; Diagnosis, Differential; Eye Diseases; Female; Humans; Infant, Newborn; Infectious Disease Tr | 2000 |
[Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
Topics: Adult; Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Child; Cocci | 2002 |
[New viewpoints on the treatment of toxoplasmosis].
Topics: Age Factors; Child, Preschool; Demeclocycline; Female; Humans; Infant; Leucomycins; Pregnancy; Pyrim | 1973 |
[A patient with toxoplasmosis and chronic liver disease].
Topics: Adult; Female; Humans; Leucomycins; Liver Diseases, Parasitic; Mercaptopurine; Pregnancy; Sulfadiazi | 1974 |
Ocular toxoplasmosis.
Topics: Abortion, Spontaneous; Adult; Animals; Diagnosis, Differential; Eye Diseases; Female; Humans; Hypers | 1969 |
3 trials available for sulfadiazine and Congenital Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; France; Humans; Infectious Disease T | 2018 |
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
Topics: Animals; Calcinosis; Chemistry, Pharmaceutical; Child; Child, Preschool; Drug Administration Schedul | 1994 |
[In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Topics: Drug Therapy, Combination; Female; Humans; Pregnancy; Pyrimethamine; Spiramycin; Sulfadiazine; Toxop | 1991 |
76 other studies available for sulfadiazine and Congenital Infection, Toxoplasma gondii
| Article | Year |
|---|---|
Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis.
Topics: Administration, Oral; Anti-Bacterial Agents; Drug Storage; Humans; Infant, Newborn; Sulfadiazine; Su | 2020 |
Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases.
Topics: Antiprotozoal Agents; Child, Preschool; Desensitization, Immunologic; Drug Hypersensitivity; Humans; | 2021 |
Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Disease Outbreaks; DNA, Protozoan; Drug Therapy, Combin | 2021 |
[DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis].
Topics: Antiprotozoal Agents; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Fatal Outcome; Hear | 2017 |
Use of polymerase chain reaction (PCR) in the diagnosis of congenital toxoplasmosis.
Topics: Antiprotozoal Agents; DNA, Protozoan; Drug Therapy, Combination; Early Diagnosis; Electroencephalogr | 2018 |
Congenital Toxoplasmosis in Tunisia: Prenatal and Neonatal Diagnosis and Postnatal Follow-up of 35 Cases.
Topics: Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, Combination; Female; Humans; Im | 2018 |
Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Topics: Alcohol Dehydrogenase; Animals; Antiprotozoal Agents; Female; Genotype; Humans; Infant, Newborn; Mic | 2019 |
Toxoplasmosis and pregnancy.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Infectious Disease Tra | 2014 |
Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.
Topics: Animals; Antiprotozoal Agents; Base Sequence; Brazil; Dihydropteroate Synthase; Drug Resistance; Fem | 2017 |
High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil.
Topics: Antiprotozoal Agents; Bone Marrow; Brazil; Child, Preschool; Female; Humans; Infant; Infant, Newborn | 2017 |
Congenital Toxoplasmosis.
Topics: Antiprotozoal Agents; Brain; Calcinosis; Female; Humans; Infant; Leucovorin; Pyrimethamine; Sulfadia | 2017 |
Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis.
Topics: Antiprotozoal Agents; Clinical Protocols; Clinical Trials as Topic; Humans; Infant, Newborn; Pyrimet | 2009 |
Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Topics: Animals; Antibodies; Artemisia annua; Azithromycin; DNA, Protozoan; Drug Therapy, Combination; Embry | 2009 |
Delayed onset of severe neonatal toxoplasmosis.
Topics: Adolescent; Antiprotozoal Agents; Female; Heart Arrest; Humans; Infant, Newborn; Male; Pregnancy; Py | 2010 |
Congenital toxoplasmosis--a report on the Danish neonatal screening programme 1999-2007.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Denmark; Drug Administration S | 2010 |
Choroidal neovascularization secondary to congenital toxoplasmosis in an infant.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Humans; Infant; Le | 2010 |
Unresolved questions about the most successful known parasite.
Topics: Animals; Child, Preschool; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertica | 2011 |
[Congenital toxoplasmosis following infection occurring late in pregnancy].
Topics: Adult; Antiprotozoal Agents; Child, Preschool; Drug Therapy, Combination; Early Diagnosis; Female; H | 2011 |
Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
Topics: Antiprotozoal Agents; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Fema | 2011 |
Case of fatal congenital toxoplasmosis associated with I/III recombinant genotype.
Topics: Adult; Antiprotozoal Agents; DNA, Protozoan; Female; Genotype; Humans; Infant, Newborn; Multilocus S | 2011 |
[Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
Topics: Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Germany; Humans; Male; Postnatal Car | 2012 |
Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Brain Diseases; Female; Fetal Growth Retardation | 2012 |
Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Brazil; Humans; Immunoglobulin M; Infant; Infant, Newbo | 2012 |
[Toxoplasmosis in sick persons].
Topics: Abortion, Spontaneous; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Co | 2002 |
Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier.
Topics: Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; | 2003 |
Congenital toxoplasmosis with unusual retinal findings.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretinitis; DNA, Protozoan; Drug Therapy, | 2003 |
THE TREATMENT OF GLANDULAR TOXOPLASMOSIS.
Topics: Child; Choroiditis; Drug Therapy; Female; Folic Acid; Humans; Lung Diseases; Lymphadenitis; Meningit | 1965 |
[Congenital toxoplasmosis: a new case of infection during pregnancy in an previously immunized and immunocompetent woman].
Topics: Angola; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cesarean Section; Drug Therapy, Combin | 2004 |
[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Pancytopenia; Parity; Pregna | 2004 |
Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis.
Topics: Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Infant; Infant, Newborn; Mass Spectro | 2005 |
Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
Topics: Antiprotozoal Agents; Denmark; Drug Monitoring; Drug Therapy, Combination; Humans; Infant; Infant, N | 2006 |
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Topics: Adolescent; Adult; Amniocentesis; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretini | 2005 |
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
Topics: Antiprotozoal Agents; Chicago; Cognition; Drug Administration Schedule; Feasibility Studies; Humans; | 2006 |
Kinetic analysis of the humoral immune response against 3 Toxoplasma gondii-recombinant proteins in infants with suspected congenital toxoplasmosis.
Topics: Aging; Animals; Antibody Formation; Antigens, Protozoan; Antiprotozoal Agents; Gene Expression Regul | 2006 |
Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Topics: Adolescent; Adult; Amniocentesis; Animals; Antimalarials; Antiprotozoal Agents; Biomarkers; Coccidio | 2007 |
Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; | 2008 |
Cataracts in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cataract; Cataract Extraction; Child; Child, Preschool; Dru | 2007 |
Experimental toxoplasmosis; effect of sulfadiazine and antiserum on congenital toxoplasmosis in mice.
Topics: Animals; Immune Sera; Mice; Sulfadiazine; Toxoplasmosis; Toxoplasmosis, Congenital | 1949 |
[Treatment of congenital toxoplasmosis].
Topics: Antibodies; Child; Child, Preschool; Drug Therapy, Combination; Folic Acid; Humans; Infant; Leucomyc | 1983 |
[Congenital toxoplasmosis; observations on the recommendation of the Public Health Council].
Topics: Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Pyrime | 1984 |
The diagnosis and treatment of toxoplasmosis.
Topics: Adult; Anti-Bacterial Agents; Antibodies; Antigens; Child; Female; Humans; Immunologic Deficiency Sy | 1983 |
[Toxoplasmosis].
Topics: Adult; Animals; Antibodies; Antimalarials; Drug Therapy, Combination; Female; Humans; Immunologic Te | 1980 |
[Difficulties in the diagnosis and treatment of toxoplasmosis].
Topics: Child; Child, Preschool; Clindamycin; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; | 1982 |
[Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Chorioretinitis; Drug Therapy, Combination; Follow-Up Studies; | 1980 |
Late cerebral relapse of congenital toxoplasmosis.
Topics: Child; Chorioretinitis; Drug Therapy, Combination; Encephalitis; Female; Humans; Pyrimethamine; Recu | 1980 |
Neurologic and developmental outcome in treated congenital toxoplasmosis.
Topics: Child Development; Female; Humans; Hydrocephalus; Infant; Infant, Newborn; Intelligence; Longitudina | 1995 |
Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Topics: Antibodies, Protozoan; Central Nervous System Diseases; Follow-Up Studies; Humans; Immunoglobulin G; | 1994 |
[Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Topics: Adult; Coccidiostats; Cross-Sectional Studies; Drug Therapy, Combination; Female; Germany; Gestation | 1995 |
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis.
Topics: Anti-Infective Agents; Brain; Calcinosis; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucov | 1996 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Drug Therapy, Combination; Female | 1996 |
[Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
Topics: Anti-Infective Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocephalus; | 1997 |
Eye manifestations of congenital toxoplasmosis.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Choroid Diseases; Cicatrix; Femal | 1997 |
Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid.
Topics: Adult; Amniotic Fluid; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; DNA, Protozoan; Drug Th | 1998 |
Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome.
Topics: Adult; Amniocentesis; Animals; Antiprotozoal Agents; Cordocentesis; DNA, Protozoan; Echoencephalogra | 1999 |
Congenital toxoplasmosis, later relapses and treatment.
Topics: Adult; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Child; Female; Follow-Up Studies; Human | 1999 |
[Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Female; Humans; Immunoglobulin A; Immunoglobulin | 1999 |
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
Topics: Antibodies, Protozoan; Antiprotozoal Agents; Drug Administration Schedule; Drug Therapy, Combination | 2000 |
[Analysis of a case of severe congenital toxoplasmosis].
Topics: Acute Disease; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antibodies, Protoz | 1999 |
[Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
Topics: Age Factors; Analysis of Variance; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; | 2002 |
[Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy].
Topics: Female; Humans; Infant, Newborn; Leucomycins; Pregnancy; Pregnancy Complications, Infectious; Sulfad | 1976 |
[Letter: Significance of Toxoplasma infections for public health].
Topics: Eye Manifestations; Humans; Immunoglobulin M; Infant, Newborn; Leucomycins; Pyrimethamine; Sulfadiaz | 1975 |
IgM ELISA follow-up of spiramycin treatment for toxoplasmosis: should the drug be prescribed in India?
Topics: Adult; Animals; Antibodies, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglob | 1992 |
Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report.
Topics: Acute Disease; Adult; Animals; Antibodies, Protozoan; Drug Therapy, Combination; Female; Fetal Blood | 1991 |
[Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
Topics: Adult; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Care; Pyrimet | 1990 |
Phenotypes and functions of lymphocytes in congenital toxoplasmosis.
Topics: Adult; Animals; Antigens, Protozoan; Child, Preschool; Concanavalin A; Humans; Infant; Interferon-ga | 1990 |
Treatment of congenital toxoplasmosis.
Topics: Adrenal Cortex Hormones; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Pyrimethamine; | 1990 |
Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.
Topics: Acquired Immunodeficiency Syndrome; Animals; Central Nervous System Diseases; Family Health; Female; | 1990 |
Toxoplasmosis in pregnancy and its transmission to the fetus.
Topics: Adolescent; Adult; Female; Gestational Age; Humans; Infant; Infant, Newborn; Leucomycins; Maternal-F | 1974 |
The management of toxoplasmosis in pregnancy.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Female; Humans; Infant; Infant, Newborn; Leucovorin; P | 1974 |
Congenital nephrotic syndrome associated with congenital toxoplasmosis.
Topics: Antigen-Antibody Complex; Blood Proteins; Cholesterol; Edema; Fluorescent Antibody Technique; Furose | 1974 |
Symptoms, transmission, prevention and treatment of toxoplasmosis.
Topics: Adult; Animals; Cat Diseases; Cats; Child; Dogs; Female; Humans; Infant; Infant, Newborn; Lymph Node | 1973 |
[Acquired toxoplasmosis].
Topics: Adult; Animals; Child; Diagnosis, Differential; Female; Humans; Lymphadenitis; Mice; Pregnancy; Pyri | 1971 |
Toxoplasmosis. With comments on risk of infection from cats.
Topics: Animals; Cat Diseases; Cats; Feces; Female; Food Contamination; Humans; Male; Meat; Pregnancy; Pregn | 1972 |
[Ocular toxoplasmosis].
Topics: Diagnosis, Differential; Eye; Female; Humans; Leucovorin; Prednisone; Pregnancy; Pregnancy Complicat | 1968 |
[Epidemiology, clinical aspects and therapy of toxoplasmosis].
Topics: Administration, Oral; Adult; Animals; Child; Complement Fixation Tests; Diagnosis, Differential; Fem | 1970 |
[Sulfadiazine, pyrimethamine, spiramycin and folic acid in congenital toxoplasmosis].
Topics: Folic Acid; Humans; Leucomycins; Pyrimethamine; Sulfadiazine; Toxoplasmosis, Congenital; Toxoplasmos | 1967 |